Inozyme Pharma Stock Forecast - Naive Prediction

INZY Stock  USD 2.98  0.26  9.56%   
The Naive Prediction forecasted value of Inozyme Pharma on the next trading day is expected to be 3.17 with a mean absolute deviation of 0.11 and the sum of the absolute errors of 7.11. Inozyme Stock Forecast is based on your current time horizon.
  
Payables Turnover is likely to rise to 1.17 in 2024, whereas Inventory Turnover is likely to drop (12.36) in 2024. . Common Stock Shares Outstanding is likely to drop to about 30.6 M in 2024. Net Loss is likely to drop to about (63.4 M) in 2024.
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Inozyme Pharma's financial statements to predict how it will affect future prices.
 
Cash  
First Reported
2019-12-31
Previous Quarter
15.2 M
Current Value
24.6 M
Quarterly Volatility
14.3 M
 
Covid
A naive forecasting model for Inozyme Pharma is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Inozyme Pharma value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Inozyme Pharma Naive Prediction Price Forecast For the 12th of December 2024

Given 90 days horizon, the Naive Prediction forecasted value of Inozyme Pharma on the next trading day is expected to be 3.17 with a mean absolute deviation of 0.11, mean absolute percentage error of 0.02, and the sum of the absolute errors of 7.11.
Please note that although there have been many attempts to predict Inozyme Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Inozyme Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Inozyme Pharma Stock Forecast Pattern

Backtest Inozyme PharmaInozyme Pharma Price PredictionBuy or Sell Advice 

Inozyme Pharma Forecasted Value

In the context of forecasting Inozyme Pharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Inozyme Pharma's downside and upside margins for the forecasting period are 0.03 and 7.12, respectively. We have considered Inozyme Pharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
2.98
3.17
Expected Value
7.12
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Inozyme Pharma stock data series using in forecasting. Note that when a statistical model is used to represent Inozyme Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria115.9951
BiasArithmetic mean of the errors None
MADMean absolute deviation0.1147
MAPEMean absolute percentage error0.0291
SAESum of the absolute errors7.1085
This model is not at all useful as a medium-long range forecasting tool of Inozyme Pharma. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Inozyme Pharma. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Inozyme Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Inozyme Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.142.736.80
Details
Intrinsic
Valuation
LowRealHigh
2.687.4811.55
Details
9 Analysts
Consensus
LowTargetHigh
19.1121.0023.31
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Inozyme Pharma. Your research has to be compared to or analyzed against Inozyme Pharma's peers to derive any actionable benefits. When done correctly, Inozyme Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Inozyme Pharma.

Other Forecasting Options for Inozyme Pharma

For every potential investor in Inozyme, whether a beginner or expert, Inozyme Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Inozyme Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Inozyme. Basic forecasting techniques help filter out the noise by identifying Inozyme Pharma's price trends.

Inozyme Pharma Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Inozyme Pharma stock to make a market-neutral strategy. Peer analysis of Inozyme Pharma could also be used in its relative valuation, which is a method of valuing Inozyme Pharma by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Inozyme Pharma Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Inozyme Pharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Inozyme Pharma's current price.

Inozyme Pharma Market Strength Events

Market strength indicators help investors to evaluate how Inozyme Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Inozyme Pharma shares will generate the highest return on investment. By undertsting and applying Inozyme Pharma stock market strength indicators, traders can identify Inozyme Pharma entry and exit signals to maximize returns.

Inozyme Pharma Risk Indicators

The analysis of Inozyme Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Inozyme Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting inozyme stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Inozyme Stock Analysis

When running Inozyme Pharma's price analysis, check to measure Inozyme Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inozyme Pharma is operating at the current time. Most of Inozyme Pharma's value examination focuses on studying past and present price action to predict the probability of Inozyme Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inozyme Pharma's price. Additionally, you may evaluate how the addition of Inozyme Pharma to your portfolios can decrease your overall portfolio volatility.